Bir Dawn Carter

CIK 00016887124 companiesFOSTER CITY, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001688712

Recent Transactions

50 trades

Award
GERON CORP$GERN
Stock Option (right to buy)
2026-05-20+220,000→ 220,000 total
Disposition to Issuer
SOLENO THERAPEUTICS INC$SLNO
Common Stock
2026-05-18−16,991→ 0 total
Award
FILANA THERAPEUTICS, INC.$FLNA
Stock Option (Right to Buy)
2025-10-21+53,000→ 53,000 total
Award
SOLENO THERAPEUTICS INC$SLNO
Common Stock
2025-06-05+3,991→ 16,991 total
Award
GERON CORP$GERN
Stock Option (right to buy)
2025-05-21+180,000→ 180,000 total
Award
SOLENO THERAPEUTICS INC$SLNO
Common Stock
2024-08-15+13,000→ 13,000 total
Award
GERON CORP$GERN
Stock Option (right to buy)
2024-05-09+180,000→ 180,000 total
Disposition to Issuer
REATA PHARMACEUTICALS INC
Employee Stock Option (right to buy)
2023-09-26−70,000→ 0 total
Disposition to Issuer
REATA PHARMACEUTICALS INC
Class A common stock
2023-09-26−33,805→ 0 total
Disposition to Issuer
REATA PHARMACEUTICALS INC
Employee Stock Option (right to buy)
2023-09-26−71,300→ 0 total
Disposition to Issuer
REATA PHARMACEUTICALS INC
Employee Stock Option (right to buy)
2023-09-26−24,000→ 0 total
Disposition to Issuer
REATA PHARMACEUTICALS INC
Employee Stock Option (right to buy)
2023-09-26−17,250→ 0 total
Disposition to Issuer
REATA PHARMACEUTICALS INC
Employee Stock Option (right to buy)
2023-09-26−63,650→ 0 total
Disposition to Issuer
REATA PHARMACEUTICALS INC
Employee Stock Option (right to buy)
2023-09-26−16,500→ 0 total
Disposition to Issuer
REATA PHARMACEUTICALS INC
Employee Stock Option (right to buy)
2023-09-26−34,500→ 0 total
Disposition to Issuer
REATA PHARMACEUTICALS INC
Employee Stock Option (right to buy)
2023-09-26−17,250→ 0 total
Sale
REATA PHARMACEUTICALS INC
Class A common stock
2023-08-16$168.33/sh−398→ 33,805 total
Sale
REATA PHARMACEUTICALS INC
Class A common stock
2023-08-15$169.04/sh−807→ 34,203 total
Conversion
REATA PHARMACEUTICALS INC
Class B common stock
2023-07-28−40,000→ 0 total
Sale
REATA PHARMACEUTICALS INC
Class A common stock
2023-07-28$164.54/sh−40,000→ 35,010 total
Exercise/Conversion
REATA PHARMACEUTICALS INC
Employee Stock Option (right to buy)
2023-07-28−40,000→ 0 total
Conversion
REATA PHARMACEUTICALS INC
Class A common stock
2023-07-28+40,000→ 75,010 total
Exercise/Conversion
REATA PHARMACEUTICALS INC
Class B common stock
2023-07-28$22.57/sh+40,000→ 40,000 total
Award
REATA PHARMACEUTICALS INC
Class A common stock
2023-07-06+4,125→ 35,010 total
Award
GERON CORP$GERN
Stock Option (right to buy)
2023-05-31+125,000→ 125,000 total
Sale
REATA PHARMACEUTICALS INC
Class A common stock
2023-05-16$80.95/sh−417→ 30,885 total
Sale
REATA PHARMACEUTICALS INC
Class A common stock
2023-05-15$85.09/sh−894→ 31,302 total
Sale
REATA PHARMACEUTICALS INC
Class A common stock
2023-03-13$86.77/sh−9,317→ 32,196 total
Conversion
REATA PHARMACEUTICALS INC
Class B common stock
2023-03-07−41,630→ 0 total
Conversion
REATA PHARMACEUTICALS INC
Class A common stock
2023-03-07+41,630→ 83,555 total
Sale
REATA PHARMACEUTICALS INC
Class A common stock
2023-03-07$85.90/sh−5,793→ 41,713 total
Exercise/Conversion
REATA PHARMACEUTICALS INC
Employee Stock Option (right to buy)
2023-03-07−41,630→ 0 total
Sale
REATA PHARMACEUTICALS INC
Class A common stock
2023-03-07$86.67/sh−200→ 41,513 total
Sale
REATA PHARMACEUTICALS INC
Class A common stock
2023-03-07$85.08/sh−36,049→ 47,506 total
Exercise/Conversion
REATA PHARMACEUTICALS INC
Class B common stock
2023-03-07$21.05/sh+41,630→ 41,630 total
Conversion
REATA PHARMACEUTICALS INC
Class A common stock
2023-03-06+48,370→ 96,879 total
Exercise/Conversion
REATA PHARMACEUTICALS INC
Class B common stock
2023-03-06$21.05/sh+48,370→ 48,370 total
Conversion
REATA PHARMACEUTICALS INC
Class B common stock
2023-03-06−48,370→ 0 total
Sale
REATA PHARMACEUTICALS INC
Class A common stock
2023-03-06$90.26/sh−14,820→ 41,925 total
Sale
REATA PHARMACEUTICALS INC
Class A common stock
2023-03-06$89.30/sh−40,134→ 56,745 total
Exercise/Conversion
REATA PHARMACEUTICALS INC
Employee Stock Option (right to buy)
2023-03-06−48,370→ 41,630 total
Sale
REATA PHARMACEUTICALS INC
Class A common stock
2023-03-03$88.25/sh−2,166→ 48,509 total
Award
REATA PHARMACEUTICALS INC
Class A common stock
2023-01-03+15,675→ 50,675 total
Award
REATA PHARMACEUTICALS INC
Employee Stock Option (right-to-buy)
2023-01-03+63,650→ 63,650 total
Award
GERON CORP$GERN
Stock Option (right to buy)
2022-05-10+125,000→ 125,000 total
Award
REATA PHARMACEUTICALS INC
Class A common stock
2022-01-03+35,000→ 35,000 total
Award
REATA PHARMACEUTICALS INC
Employee Stock Option (right to buy)
2022-01-03+70,000→ 70,000 total
Award
GERON CORP$GERN
Stock Option (right to buy)
2021-05-11+83,000→ 83,000 total
Award
REATA PHARMACEUTICALS INC
Employee Stock Option (right to buy)
2021-01-04+16,500→ 16,500 total
Exercise/Conversion
REATA PHARMACEUTICALS INC
Employee Stock Option (right to buy)
2020-11-09−60,000→ 90,000 total

Companies

Recent Filings

Address

C/O GERON CORPORATION 919 EAST HILLSDALE BOULEVARD, SUITE 250

FOSTER CITY, CA, 94404

View on SEC.gov